BAT Korea Halves Prices of New Heated Tobacco Products

May.05.2023
BAT Korea Halves Prices of New Heated Tobacco Products
British American Tobacco (BAT) cuts prices by 50% for its new product in South Korea to increase pod sales, raising concerns over its long-term profitability.

Recently, according to a report from South Korean media outlet "Today's Economy," British American Tobacco (BAT) Korea has cut the price of their new heated but not burned product by half, within two months of its launch. The move is an attempt by BAT to boost sales of their pod product by offering lower prices. However, with decreasing profitability, the market is becoming increasingly skeptical about the long-term viability of this share-focused strategy.


Starting from April 17th, BAT is selling Glo Hyper X2 at a 50% discount off the original price. Although it is promoted as a sales campaign, it will continue until June 8th, which is essentially a price reduction.


Comparison of prices for non-burning products in the South Korean market | Graphic by 2FIRSTS.


BAT is increasing its market share through continuous promotional activities.


In 2021, the company offered a 90% discount on the price of the product Glo, selling it for 9,500 Korean won during a three-week pre-sale period. Subsequently, the company continued to sell the product at the same discounted rate throughout the year through several promotional events.


The "Glo Pro Slim" continued the promotional campaign when it was subsequently released.


KT&G and PMI Korea dominate the heated tobacco products market in South Korea with approximately 40% market share each. However, BAT's low pricing strategy has led to an increase in their market share. According to BAT, their market share has jumped from 6.04% in 2020 to 11.72% last year.


South Korean financial media outlet "Today's Finance" believes that the strategy of BAT is to generate actual revenue by introducing exclusive replacement pods. They initially used universal pods, but now have launched promotion-specific pods that are not compatible with other non-combustible heating products under their umbrella.


The idea is that the more users a product has, the greater its pod sales volume will be.


Dual Decline of Profits and Profit Margins


However, analysts have stated that this strategy is leading to a deterioration in the profitability of BAT.


Last year, South Korean BAT companies saw a 14.3% increase in revenue, reaching 539.8 billion Korean won, but operating profits decreased by 11.9% to 44.6 billion Korean won. Operating profit margins also declined from 10.7% to 8.3%. However, as the company did not disclose the performance of its South Korean subsidiary, Rothman's SpiceVibe, the specific amount of losses is still unclear.


The tobacco industry believes that the price threshold for low-end heated non-burning products is between 30,000 and 40,000 Korean won in order to maintain profit margins.


Once the selling price drops below this price, it means a loss in terms of cost.


An industry expert states:


This is a nascent market that only holds a 15% share of the entire tobacco market, hence a product expansion strategy may prove effective.


However, "BAT (Baidu, Alibaba, and Tencent) will find it difficult to continue bearing the losses generated by promotions and low-priced products.


Regarding this matter, a spokesperson for BAT stated, "We will focus on product sales in order to establish our position in the heated non-combustion market.


Related Reading:


PMI (Philip Morris International) teams up with KT&G (Korea Tobacco & Ginseng Corporation) to seize the global market, as BAT (British American Tobacco) aims to attract Korean customers through low pricing strategies.


KT&G and PMI compete for market leadership in South Korea.


The PMI profits of the South Korean market have increased by 163%, while BAT has experienced a decline of 12%.


ELFBAR, a South Korean agent, has reported an increase in initial orders and is aiming to sell 2 million units in South Korea this year.


South Korea may abandon the tax increase on HNB, which currently has a tax rate of 90.4% of regular cigarettes.


Reference/source:


Half-price just two months after release...How long will BAT's e-cigarette expansion strategy continue?


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

KT&G says lil reached about US$2.924 billion in cumulative sales and is expanding overseas
KT&G says lil reached about US$2.924 billion in cumulative sales and is expanding overseas
KT&G said its HNB brand lil has grown since launch, reporting KRW 7.8 billion (about US$5.304 million) in sales in 2017 and about KRW 4.3 trillion (about US$2.924 billion) in cumulative sales by last year’s third quarter, with KRW 5 trillion (about US$3.400 billion) described as within reach. KT&G said lil has entered more than 30 countries and supplies some products abroad via a partnership with PMI.
Jan.13 by 2FIRSTS.ai
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
FDA Authorizes Glas Vape but Flavor Hopes Fall Short
The FDA has added Glas products to its authorized electronic nicotine delivery systems (ENDS) list, granting Marketing Granted Orders (MGOs) to the Glas G DEVICE and a BLONDE TOBACCO pod. The decision expands the number of FDA-authorized ENDS products to 41, marking the first new authorization since Juul’s approvals in July 2025. However, widely anticipated non-tobacco flavored products were not approved.
Mar.13
Product | Pixx Nicotine Toothpicks Listed on UK Retail Website, Said to Be Unaffected by Upcoming Vape Tax
Product | Pixx Nicotine Toothpicks Listed on UK Retail Website, Said to Be Unaffected by Upcoming Vape Tax
2Firsts has noted that a nicotine toothpick product named Pixx has appeared on a UK retailer website. The product page describes it as a smoke-free nicotine product, and the packaging image shows “UK MADE.” A nicotine-industry professional wrote on LinkedIn that the UK is set to introduce vape tax changes that may increase pressure on the retail side, and said Pixx is expected not to be included in the upcoming vape tax.
Mar.05 by 2FIRSTS.ai
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
A Louisiana lawmaker has introduced HB 302, which would prohibit businesses from selling vapor products within 300 feet of schools. The bill would measure the distance by a person walking on the sidewalk from the nearest point on school property to the nearest point of the business. It would also give the commissioner authority to modify how the distance is calculated, while maintaining the 300-foot limit.
Feb.26 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24